Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer

被引:20
作者
Petraki, Constantina [1 ]
Youssef, Youssef M. [2 ,3 ,6 ]
Dubinski, William [2 ,3 ,6 ]
Lichner, Zsuzsanna [2 ,3 ,6 ]
Scorilas, Andreas [4 ]
Pasic, Maria D. [2 ]
Komborozos, Vassilios [5 ]
Khalil, Bishoy [3 ,6 ]
Streutker, Catherine [2 ,3 ,6 ]
Diamandis, Eleftherios P. [2 ]
Yousef, George M. [2 ,3 ,6 ]
机构
[1] Metropolitan Hosp, Dept Pathol, Athens, Greece
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[3] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada
[4] Univ Athens, Fac Biol, Dept Biochem & Mol Biol, Athens 15701, Greece
[5] Evangelismos Med Ctr, Dept Gen Surg, Athens, Greece
[6] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
关键词
KLK; Kallikreins; KLK10; Colorectal cancer; Prognosis; CLINICAL-SIGNIFICANCE; GENE-EXPRESSION; SERINE-PROTEASE; CELL CARCINOMA; FAMILY; METHYLATION; MARKERS;
D O I
10.1007/s13277-012-0368-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognosis of patients with colorectal cancer (CRC) is assessed through conventional clinicopathological parameters, which are not always accurate. Members of the human kallikrein-related peptidases gene family represent potential cancer biomarkers. The aim of this study was to investigate the expression of human tissue kallikrein-related peptidase 10 (KLK10) by immunohistochemistry in CRC, to correlate this expression with various histopathological and clinical variables, and to evaluate its significance as a predictor of disease outcome. KLK10 expression was evaluated by immunohistochemistry and a combined expression score was calculated for each case based on intensity and percentage of positivity. A statistically significant positive association was observed between KLK10 and tumor stage and liver metastases (p = 0.015 and p = 0.035, respectively). Paradoxically, a negative association was observed between KLK10 and tumor grade (p = 0.009). Kaplan-Meier survival curves and univariate analysis showed that both KLK10 expression and stage had statistically significant correlations with disease-free survival (DFS) (p = 0.030 and p < 0.001, respectively) and overall survival (p = 0.010 and p = 0.001, respectively). Cox multivariate analysis showed that both KLK10 expression and stage were independent predictors of unfavorable DFS (p = 0.057 and p = 0.001, respectively) and overall survival (p = 0.009 and p = 0.001, respectively). In conclusion, KLK10 immunostaining is an independent prognostic marker in patients with CRC.
引用
收藏
页码:1209 / 1214
页数:6
相关论文
共 33 条
[1]   The tissue kallikrein family of serine proteases: Functional roles in human disease and potential as clinical [J].
Clements, JA ;
Willemsen, NM ;
Myers, SA ;
Dong, Y .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2004, 41 (03) :265-312
[2]   Personalized Medicine: Marking a New Epoch in Cancer Patient Management [J].
Diamandis, Maria ;
White, Nicole M. A. ;
Yousef, George M. .
MOLECULAR CANCER RESEARCH, 2010, 8 (09) :1175-1187
[3]   Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers [J].
Emami, Nashmil ;
Diamandis, Eleftherios P. .
CLINICAL CHEMISTRY, 2008, 54 (10) :1600-1607
[4]   Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer [J].
Feng, Bo ;
Xu, Wei-Bin ;
Zheng, Min-Hua ;
Ma, Jun-Jun ;
Cai, Qu ;
Zhang, Yi ;
Ji, Jun ;
Lu, Ai-Guo ;
Qu, Ying ;
Li, Jian-Wen ;
Wang, Ming-Liang ;
Hu, Wei-Guo ;
Liu, Bing-Ya ;
Zhu, Zheng-Gang .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (10) :1596-1603
[5]  
Feng Bo, 2006, Zhonghua Wai Ke Za Zhi, V44, P623
[6]  
Goyal J, 1998, CANCER RES, V58, P4782
[7]  
Idikio HA, 2010, INT J CLIN EXP PATHO, V3, P169
[8]   Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer [J].
Kioulafa, M. ;
Kaklamanis, L. ;
Stathopoulos, E. ;
Mavroudis, D. ;
Georgoulias, V. ;
Lianidou, E. S. .
ANNALS OF ONCOLOGY, 2009, 20 (06) :1020-1025
[9]  
Li B, 2001, CANCER RES, V61, P8014
[10]  
Liu XL, 1996, CANCER RES, V56, P3371